TY - JOUR
T1 - Cutaneous Presentation of Juvenile Chronic Myelogenous Leukemia
T2 - A Diagnostic and Therapeutic Dilemma
AU - Sires, Ulrike I.
AU - Mallory, Susan B.
AU - Hess, Jay L.
AU - Keating, James P.
AU - Bloomberg, Gordon
AU - Dehner, Louis P.
PY - 1995/12
Y1 - 1995/12
N2 - Abstract: Annular, erythematous, circinate plaques were the first manifestation of juvenile chronic myelogenous leukemia (JCML) in an otherwise healthy 2.5‐year‐old boy who had had these lesions since 6 months of age. The lesions showed an atypical hematopoietic infiltrate on biopsy. Biopsy of a bone marrow specimen and peripheral blood smear were normal six months before leukemic transformation. At 3 years of age the boy developed splenomegaly, thrombocytopenia, and petechiae, and a bone marrow aspirate and cell marker studies were regarded as consistent with, if not diagnostic of, JCML. Four previous cases of cutaneous leukemic infiltrate associated with JCML have been published. Our patient had recurring urticarial‐like plaques for two years before the initial bone marrow finding of JCML. Given the poor prognosis and progressively evolving course of JCML, it may be appropriate to consider therapy before bone marrow changes, based on the presence of the cutaneous eruption with the appropriate findings on skin biopsy and an elevated fetal hemoglobin.
AB - Abstract: Annular, erythematous, circinate plaques were the first manifestation of juvenile chronic myelogenous leukemia (JCML) in an otherwise healthy 2.5‐year‐old boy who had had these lesions since 6 months of age. The lesions showed an atypical hematopoietic infiltrate on biopsy. Biopsy of a bone marrow specimen and peripheral blood smear were normal six months before leukemic transformation. At 3 years of age the boy developed splenomegaly, thrombocytopenia, and petechiae, and a bone marrow aspirate and cell marker studies were regarded as consistent with, if not diagnostic of, JCML. Four previous cases of cutaneous leukemic infiltrate associated with JCML have been published. Our patient had recurring urticarial‐like plaques for two years before the initial bone marrow finding of JCML. Given the poor prognosis and progressively evolving course of JCML, it may be appropriate to consider therapy before bone marrow changes, based on the presence of the cutaneous eruption with the appropriate findings on skin biopsy and an elevated fetal hemoglobin.
UR - https://www.scopus.com/pages/publications/0029565053
U2 - 10.1111/j.1525-1470.1995.tb00203.x
DO - 10.1111/j.1525-1470.1995.tb00203.x
M3 - Article
C2 - 8747588
AN - SCOPUS:0029565053
SN - 0736-8046
VL - 12
SP - 364
EP - 368
JO - Pediatric Dermatology
JF - Pediatric Dermatology
IS - 4
ER -